Cisco DNA Licensing: Subscription Transition Guide

What is Cisco DNA?

Cisco DNA (Digital Network Architecture) is Cisco's software-defined networking platform that runs on top of Catalyst 9000 hardware—primarily switches and routers. Unlike traditional perpetual licensing for IOS software, DNA is a mandatory subscription model for all new Catalyst deployments, marking a fundamental shift in how Cisco licenses enterprise network infrastructure.

Historically, Catalyst switches came with perpetual "base" IOS-XE licenses, which customers could own forever. Starting with Catalyst 9000 (launched 2017), Cisco bundled hardware with DNA subscriptions, bundling visibility, automation, and assurance capabilities that previously required separate purchases.

DNA sits on top of IOS-XE base—it's the software stack providing:

• Network visibility — real-time topology, device health, flow analytics
• Intent-based networking — policy-driven automation (SD-Access)
• AI/ML analytics — encrypted traffic analysis (ETA), anomaly detection
• Assurance — end-to-end monitoring, proactive insights
• Provisioning — template-driven device onboarding

If you're buying new Catalyst 9000 switches, DNA subscriptions are non-negotiable. Legacy Catalyst 3850, 4500, and 6800 switches can continue with perpetual licenses, but Cisco actively migrates customers toward Catalyst 9000 + DNA bundles, especially for renewal and expansion scenarios.

DNA Licensing Tiers: Essentials, Advantage, Premier

Cisco offers three DNA subscription tiers, each bundling increasing levels of functionality:

DNA Essentials

The baseline tier, covering basic network operations:

• Network visibility and device inventory
• Simple automation and policy templates
• SD-Access lite (simplified fabric deployment)
• Event alerting and basic health monitoring
• No DNA Center platform license (requires separate purchase)

DNA Advantage

The midmarket standard, adding advanced analytics and full SD-Access:

• All Essentials features
• Full SD-Access (fabric, identity-based networking, micro-segmentation)
• AI-driven network analytics and encrypted traffic analysis (ETA)
• Assurance engine with predictive alerting
• Still no DNA Center platform license—purchased separately

DNA Premier

The premium tier, bundling DNA Center platform + full endpoint analytics:

• All Advantage features
• DNA Center platform license (Catalyst Center appliance license) included
• AI endpoint analytics (user/device behavior modeling)
• Full telemetry and advanced threat detection
• Most comprehensive support and feature access

Most organizations choose DNA Advantage as the sweet spot—it covers full SD-Access and assurance without forcing the DNA Center platform purchase that Premier demands. Enterprise deployments with >500 switches often evaluate Premier for the included DNA Center license.

DNA Center (Catalyst Center) Pricing

DNA Center is the management and policy platform for DNA networks. It can be deployed as:

• Physical appliance (DN2-HW-APL, DN2-HW-APL-L) — ~$50K-$80K hardware cost
• Virtual appliance (DN2-HW-VIR) — virtual equivalent, cheaper
• SaaS/Catalyst Center Cloud — Cisco-hosted option (newer, limited adoption)

DNA Center requires an annual platform license:

• Standalone DNA Center license (~$15K-$25K/year) — can be purchased separately
• Bundled in DNA Premier subscription — included with Premier tier

For small deployments (<50 switches), DNA Center may be overkill; SD-Access can be provisioned via CLI or third-party tools. For large campuses (200+ switches), DNA Center becomes the operational necessity, making Premier or bundled Center licensing a real budget item.

The Perpetual-to-Subscription Transition

Cisco's shift from perpetual to subscription has been gradual but deliberate:

Legacy World (Pre-Catalyst 9000)

Catalyst 3850, 4500, 6800 switches shipped with perpetual "base" IOS-XE licenses. Customers paid once, owned the license forever, and renewed SmartNet annually for support. Additional features (SD-Access, assurance) required separate license purchases.

Catalyst 9000 Era (2017+)

Catalyst 9000 (Catalyst 9300, 9400, 9500, 9600) launched with DNA subscriptions mandatory. Cisco positioned this as "bundled value"—for one subscription, you get hardware + IOS-XE + DNA features. In reality, this forced organizations to:

• Pay for 3-5 year DNA subscriptions upfront
• Commit device counts across the subscription term (True Forward)
• Plan hardware refresh and capacity within the contract window

What "Perpetual" Customers Actually Got

Some Catalyst 9000 sales in 2017-2019 claimed to offer "perpetual" DNA licenses. In practice, these were perpetual software rights without paid support—essentially "perpetual with no SmartNet"—which is operationally worthless in production networks. Cisco successfully repositioned all new sales to subscriptions.

Current Reality

As of 2026, DNA subscriptions are Cisco's only licensing model for Catalyst 9000 and all new network hardware. Legacy perpetual Catalyst customers are being aggressively migrated via end-of-life campaigns and renewal pressure. If your org still has perpetual Catalyst switches, expect Cisco to bundle Catalyst 9000 + DNA into any expansion or refresh RFP.

True Forward Mechanics: The Hidden Cost Risk

True Forward is Cisco's term for a licensing model where your contracted device count can never decrease, only increase. This is both a price guarantee and a financial risk.

How True Forward Works

When you sign a DNA subscription contract for, say, 300 switches, you commit to that minimum for the 3 or 5-year term. If you later:

• Retire 50 switches (consolidation, data center closure) — you still pay for 300
• Determine 250 is sufficient — you still pay for 300
• Replace 50 old switches with 60 new ones — you can increase to 360, but never drop below 300

This is disastrous for organizations with uncertain network needs, undergoing M&A, or planning data center migrations. A Fortune 500 financial services firm committed to 800 Catalyst 9000 switches in a 3-year DNA Advantage contract, then sold a division and needed only 600. They had to pay for 800 DNA licenses for the full 3 years—approximately $2.1M in unnecessary costs.

How to Mitigate True Forward

Three strategies:

1. Start conservatively — contract only devices deployed in year 1, add via amendments as you grow
2. Negotiate True-Down in year 1 — push Cisco to allow 1 downward true-up in months 12-18 if actual deployment differs from forecast
3. Use an ELA (Enterprise License Agreement) — ELAs often include true-down provisions and pooled device counts across multiple contract years

DNA Subscription Pricing Table

DNA is priced per-switch, per-year, with discounts for 5-year commitments vs annual or 3-year terms. Pricing varies by region and Cisco list price, but this table reflects typical negotiated rates (2026):

Notes:

• These are approximate Cisco list prices; actual negotiated rates are typically 15-35% lower
• Bundling DNA with Catalyst 9000 hardware often yields additional 10-15% bundled discounts
• Enterprise customers on ELAs can negotiate tiers within the EA, allowing blended pricing
• Regional and channel discounts vary; Tier 1 resellers (Arrow, Tech Data) offer better discounts than direct

Cost Impact Analysis: 500-Switch Estate

Let's model the 3-year and 5-year total cost of ownership (TCO) for a mid-market organization with 500 Catalyst 9000 switches deployed across campuses:

Key Takeaways:

• DNA Advantage is expensive — 2.5x perpetual + SmartNet on a 3-year basis
• 5-year commitments offer 20% savings per year vs 3-year, but lock you in longer
• DNA Premier is only justified if you need DNA Center—otherwise, buy Advantage + standalone Center license at lower cost
• Bundling hardware + DNA together yields 15-25% additional savings compared to separate purchases

8 Negotiation Tactics for DNA Licensing

Tactic 1: Bundle Hardware and DNA for 15-25% Discount

Cisco's standard playbook is to quote hardware and DNA separately, allowing them to hold software pricing stable while offering hardware discounts. Flip this: bundle all Catalyst 9000 hardware and DNA subscriptions into a single RFP line item. Demand a consolidated discount of 15-25% off the combined value. Resellers (Arrow, Tech Data, Insight) have authority to offer 18-22% on bundles; leverage competing RFPs to lock it in.

Tactic 2: Push for 5-Year Terms with Price Locks

5-year commitments give you annual pricing discounts, but more importantly, they provide price protection. Lock Cisco into per-switch-per-year rates that don't escalate beyond 2-3% annually. This guards against Cisco's typical 5-8% year-over-year price increases. In a 500-switch scenario, locked pricing saves 8-12% vs allowing annual increases.

Tactic 3: Challenge "Mandatory" DNA—Explore IOS-XE Base Only

Cisco's positioning suggests DNA is mandatory. In reality, you can deploy Catalyst 9000 without DNA subscriptions using only the base IOS-XE license included with hardware. You lose visibility, automation, and assurance, but basic switching and routing work. If your use case is simple (campus LAN without SD-Access or advanced analytics), challenge the DNA requirement. This leverage forces Cisco to justify the cost via a proper ROI analysis.

Tactic 4: Use Juniper / Arista / HPE Aruba Competitive Alternatives

Cisco's position weakens significantly when faced with an alternative RFP. Juniper (MX, PTX switching), Arista (7050 campus), and HPE Aruba (8320) all offer switching features without DNA-style subscription locks. Run a competitive RFP with 2-3 vendors; the savings pressure on Cisco alone justifies 10-15% discounts immediately. Many organizations avoid this because Cisco is "the standard"—but Cisco counts on it.

Tactic 5: Negotiate DNA Center Appliance as Free or Heavily Discounted

DNA Center hardware (DN2-HW-APL) costs $50K-$80K plus annual platform licensing ($15K-$25K). If you're committing to 500+ switches and 3-5 year terms, demand the DNA Center appliance at zero cost or 50-60% discount. Position it as "operational enablement" for your DNA commitment. Many resellers have authority to include hardware for free on large deals; Cisco's margin on DNA Center allows this.

Tactic 6: Negotiate True-Down Rights in First 12 Months

True Forward is standard, but you can carve out an exception. Negotiate a "True-Down in Year 1" clause allowing you to reduce committed device count by up to 15-20% during months 12-18 based on actual deployment data. This protects you if your network grows slower than projected or if M&A shrinks your estate. Cisco typically resists but will agree if you're signing a long-term ELA or large multi-year deal.

Tactic 7: Time Purchases for Cisco Q4 (July-August) for Best Discounts

Cisco's fiscal year ends September 30. Q4 (July-August) is critical for hitting annual quotas, and sales teams have maximum discount authority. Launch RFPs in June, target deal closure by late August. You'll see 20-30% discounts in Q4 vs 10-15% in other quarters. Plan your budget cycles to align with Cisco's fiscal calendar.

Tactic 8: Use an ELA (Enterprise License Agreement) to Pool and Negotiate Terms

If you're already on a Cisco ELA or considering one, add DNA subscriptions to the EA framework. ELAs allow pooled device counts (overage flexibility), blended per-unit pricing across tiers, and custom true-down provisions. An EA-based DNA contract typically yields 25-35% lower per-unit cost than standalone subscriptions because Cisco incentivizes consolidation. For organizations with >300 switches or $2M+ annual Cisco spend, an ELA negotiation is mandatory.

DNA vs Cisco ONE vs Enterprise Agreement

Cisco offers three frameworks for buying DNA, and understanding the differences is critical for pricing and terms:

Standalone DNA Subscriptions

Buy DNA Essentials/Advantage/Premier directly from a Cisco reseller. Pricing is list-based with typical 15-25% discounts. Terms are fixed (1-year, 3-year, 5-year), and you manage true-forward risk independently. Best for: smaller estates (<100 switches), single-purpose deployments, or organizations without existing Cisco relationships.

Cisco ONE

Cisco ONE is Cisco's subscription bundling framework that combines network, security, collaboration, and cloud licensing into a single "software suite." DNA can be added to ONE, allowing you to:

• Blend per-unit pricing across software categories
• Pool device counts and users globally
• Negotiate volume discounts across products (DNA + Cisco Meraki + Webex + security)
• Gain flexibility to shift budget between categories year-to-year

ONE contracts are typically 3-5 years with annual true-ups. Pricing can be 20-35% lower than standalone DNA because Cisco wants to consolidate your spending. If you're already on Cisco ONE or considering it, DNA subscriptions added to ONE are significantly cheaper than separate RFQs.

Enterprise License Agreement (ELA)

An ELA is a broad Cisco framework covering all products (network, security, software, services) with custom terms negotiated upfront. DNA subscriptions under an ELA benefit from:

• Pooled device counts — total contracted switches can be rebalanced across contract years
• True-down flexibility — annual true-ups allow reductions if deployment changes
• Blended per-unit pricing — Cisco incentivizes consolidation with better rates
• Custom term structures — multi-year deals with price protection and escalation caps
• Bundle pricing — DNA + security + Meraki all bundled at higher discounts

ELAs are negotiated end-to-end, with legal, commercial, and technical teams involved. Typical ELA DNA pricing is 25-40% below standalone subscriptions for organizations spending >$2M annually.

Frequently Asked Questions